| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.33 | 0.05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |